|
|||||
|
|
The use of continuous infusion topotecan in persistent and recurrent ovarian cancer |
|
| Authors: | J. C. Elkas,C. H. Holschneider,B. Katz,A. J. Li,R. Louie,K. F. Mcgonigle,& J. S. Berek |
| Affiliation: | Division of Gynecologic Oncology, Department of Obstetrics &Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California |
| Abstract: | |
| Keywords: | continuous infusion ovarian cancer recurrent persistent disease second line therapy topotecan |